Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fortin

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Clinical Neurology and Neurosurgery|January 26, 2016
TBI prognosis calculator: A mobile application to estimate mortality and morbidity following traumatic brain injuryChristian Iorio-Morin, David Fortin, Jocelyn Blanchard
The AAPS Journal|May 1, 2008
Recent advances in blood-brain barrier disruption as a CNS delivery strategyMarc-André Bellavance, Marie Blanchette, David Fortin
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 6, 2006
MR-pathological comparison in F98-Fischer glioma model using a human gantryJocelyn Blanchard, David Mathieu, Yves Patenaude, et al.
Targeted Oncology|March 5, 2014
Transforming growth factor-beta and its implication in the malignancy of gliomasLaurent-Olivier Roy, Marie-Belle Poirier, David Fortin
Investigational New Drugs|March 11, 2016
Convection-enhancement delivery of liposomal formulation of oxaliplatin shows less toxicity than oxaliplatin yet maintains a similar median survival time in F98 glioma-bearing rat modelMinghan Shi, David Fortin, Benoit Paquette, et al.
Investigational New Drugs|August 15, 2015
Chloroquine inhibits the malignant phenotype of glioblastoma partially by suppressing TGF-betaLaurent-Olivier Roy, Marie-Belle Poirier, David Fortin
International Journal of Molecular Sciences|April 13, 2018
Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM TumorsLaurent-Olivier Roy, Marie-Belle Poirier, David Fortin
Journal of Neuroscience Methods|April 13, 2025
Detailed characterization of partial tumor resection in the Syngeneic Fischer/F98 Glioma ModelLaurence Déry, Gabriel Charest, Brigitte Guérin, et al.
International Journal of Pharmaceutics|June 25, 2010
Uptake and intracellular release kinetics of liposome formulations in glioma cellsMarc-André Bellavance, Marie-Belle Poirier, David Fortin
Current Neurology and Neuroscience Reports|April 9, 2002
Chemotherapeutic dose intensification for treatment of malignant brain tumors: recent developments and future directionsDale F Kraemer, David Fortin, Edward A Neuwelt
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Clinical Neurology and Neurosurgery|January 26, 2016
TBI prognosis calculator: A mobile application to estimate mortality and morbidity following traumatic brain injuryChristian Iorio-Morin, David Fortin, Jocelyn Blanchard
The AAPS Journal|May 1, 2008
Recent advances in blood-brain barrier disruption as a CNS delivery strategyMarc-André Bellavance, Marie Blanchette, David Fortin
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 6, 2006
MR-pathological comparison in F98-Fischer glioma model using a human gantryJocelyn Blanchard, David Mathieu, Yves Patenaude, et al.
Targeted Oncology|March 5, 2014
Transforming growth factor-beta and its implication in the malignancy of gliomasLaurent-Olivier Roy, Marie-Belle Poirier, David Fortin
Investigational New Drugs|March 11, 2016
Convection-enhancement delivery of liposomal formulation of oxaliplatin shows less toxicity than oxaliplatin yet maintains a similar median survival time in F98 glioma-bearing rat modelMinghan Shi, David Fortin, Benoit Paquette, et al.
Investigational New Drugs|August 15, 2015
Chloroquine inhibits the malignant phenotype of glioblastoma partially by suppressing TGF-betaLaurent-Olivier Roy, Marie-Belle Poirier, David Fortin
International Journal of Molecular Sciences|April 13, 2018
Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM TumorsLaurent-Olivier Roy, Marie-Belle Poirier, David Fortin
Journal of Neuroscience Methods|April 13, 2025
Detailed characterization of partial tumor resection in the Syngeneic Fischer/F98 Glioma ModelLaurence Déry, Gabriel Charest, Brigitte Guérin, et al.
International Journal of Pharmaceutics|June 25, 2010
Uptake and intracellular release kinetics of liposome formulations in glioma cellsMarc-André Bellavance, Marie-Belle Poirier, David Fortin
Current Neurology and Neuroscience Reports|April 9, 2002
Chemotherapeutic dose intensification for treatment of malignant brain tumors: recent developments and future directionsDale F Kraemer, David Fortin, Edward A Neuwelt
Pageof 9